The novel serine protease tumor-associated differentially expressed gene-14 (KLK8/Neuropsin/Ovasin) is highly overexpressed in cervical cancer
Open Access
- 31 January 2004
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 190 (1), 60-66
- https://doi.org/10.1016/j.ajog.2003.07.020
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Cancer gene therapy with tissue inhibitors of metalloproteinases (TIMPs).Current Gene Therapy, 2002
- Increased expression of protease M in ovarian tumors.Tumor Biology, 2001
- Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention.Tumor Biology, 2001
- Type II Transmembrane Serine ProteasesPublished by Elsevier BV ,2001
- Ovarian tumor cells express a novel multi-domain cell surface serine proteaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Urokinase plasminogen activator: A prognostic marker in multiple types of cancerJournal of Surgical Oncology, 1999
- Molecular cloning of seprase: a serine integral membrane protease from human melanomaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1997
- Molecular forms of prostate-specific antigen and the human kallikrein gene family: A new eraUrology, 1995
- Cancer metastasis and angiogenesis: An imbalance of positive and negative regulationCell, 1991
- A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cellsBiochemistry, 1988